inulin
Drug data last refreshed 22h ago · AI intelligence enriched 1mo ago
Inulin and Sodium Chloride is an injectable diagnostic agent approved in 1940 used primarily as a renal function assessment tool. It measures glomerular filtration rate (GFR) and kidney clearance in clinical and research settings. The product works by being filtered by the kidneys with minimal protein binding or tubular reabsorption.
Long-established diagnostic product approaching loss of exclusivity with minimal market-facing commercial infrastructure.
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Inulin Gel in Combination With Ipilimumab and Nivolumab for the Treatment of Metastatic or Locally Advanced Kidney Cell Cancer, ICON Trial
The Effects of Oral Fructanase Administration on Gastrointestinal Symptoms After Inulin Challenge in Healthy Adults
Impact of Native Chicory Inulin on Change and Persistence of Gut Microbiota
Oral Inulin in Combination With Fruquintinib Plus Sintilimab as Third- or Further-line Treatment in Metastatic Colorectal Cancer
Safety and Tolerability Trial of Microbial Inulinase
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
This legacy diagnostic product shows minimal career velocity with zero linked jobs currently available. Working on inulin offers limited growth potential as the product approaches exclusivity loss with stable but modest market demand.